GlassScriptPhysician profile
Terence J Clarke
NPI 1326090911
$11,839.73
in general payments reported to CMS, 2019-2025
12 companies · $88.75 in 2025
The $88.75 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,395 · 2020: $3,431 · 2022: $3,311 · 2023: $527 · 2024: $2,087 · 2025: $88.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,663 · Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,663.26 |
| Food and Beverage | $1,039.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,206.69 | 2019-2023 | |
| Medical Device Business Services, INC. | $3,018.62 | 2019-2024 | Echelon Flex |
| Medtronic, INC. | $953.64 | 2022 | |
| Novo Nordisk INC | $212.98 | 2019-2024 | Wegovy |
| Ethicon US, LLC | $135.69 | 2019-2024 | Echelon; Endopath, Linx Reflux Management System |
| Teleflex LLC | $97.38 | 2023-2024 | Titan Sgs, Titan Sgs Standard Gastric Stapler |
| Lilly USA, LLC | $65.80 | 2024-2025 | Zepbound |
| Vertex Pharmaceuticals Incorporated | $49.25 | 2025 | |
| Bard Peripheral Vascular, INC. | $45.89 | 2024 | Venclose Maven Catheter |
| Acell, INC. | $28.60 | 2020 | |
| Currax Pharmaceuticals LLC | $14.33 | 2025 | Contrave |
| Covidien LP | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terence Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.